China Raises Subsidy for Basic Public Health Services, Targets Vulnerable Groups
Policy / Regulatory

China Raises Subsidy for Basic Public Health Services, Targets Vulnerable Groups

HuaDong Medicine's HDM2020 Gains NMPA Approval for Clinical Trials
CompanyDrug

Hua Dong Medicine’s HDM2020 Gains NMPA Approval for Clinical Trials

Cutia Therapeutics' Phase III Results for Lidocaine-Tetracaine Cream to be Presented at CSD Meeting
CompanyDrug

Cutia Therapeutics’ Phase III Results for Lidocaine-Tetracaine Cream to be Presented at CSD Meeting

Novartis Completes Acquisition of Regulus Therapeutics for ADPKD Treatment
CompanyDeals

Novartis Completes Acquisition of Regulus Therapeutics for ADPKD Treatment

Sino Biopharmaceutical's LM-108 Gains CDE BTD for Gastric Adenocarcinoma
CompanyDrug

Sino Biopharmaceutical’s LM-108 Gains CDE BTD for Gastric Adenocarcinoma

Mabwell Bioscience Grants Qilu Pharma Exclusive Rights to Mailisheng in Greater China
CompanyDeals

Mabwell Bioscience Grants Qilu Pharma Exclusive Rights to Mailisheng in Greater China

Fosun Pharma's Serplulimab Approved for ES-SCLC in the UK and India
CompanyDrug

Fosun Pharma’s Serplulimab Approved for ES-SCLC in the UK and India

Sanofi's Riliprubart Granted Orphan Drug Status for Antibody-Mediated Rejection Treatment
CompanyDrug

Sanofi’s Riliprubart Granted Orphan Drug Status for Antibody-Mediated Rejection Treatment

Bio-Thera Solutions Initiates Phase III Trial of BAT8006 for Platinum-Resistant Ovarian Cancer
CompanyDrug

Bio-Thera Solutions Initiates Phase III Trial of BAT8006 for Platinum-Resistant Ovarian Cancer

AstraZeneca Restructures to Form Gastrointestinal Oncology Business Unit
Company

AstraZeneca Restructures to Form Gastrointestinal Oncology Business Unit

EMA Panel Recommends Brukinsa Tablet Formulation for Approval
CompanyDrug

EMA Panel Recommends Brukinsa Tablet Formulation for Approval

Sinocelltech Wins NMPA Clearance for TriAb SCTB39G in Solid Tumors
CompanyDrug

Sinocelltech Wins NMPA Clearance for TriAb SCTB39G in Solid Tumors